Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device.
Company Details
- Employees
- 17
- Founded
- -
- Address
- 8 St Marys St, Boston,massachusetts 02215,united States
- co****@****euko.io
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- leuko.io
- HQ
- Boston, Massachusetts
Leuko Questions
Leuko's website is leuko.io
Leuko's LinkedIn profile is https://www.linkedin.com/company/leuko
Leuko has
17 employees.
View email and phone details for 17
employees at Leuko.
Leuko's industry is
Medical Equipment Manufacturing
Leuko's top competitors are
Jaxbio,
Predicta Biosciences,
Noze,
Gnosko Bio,
Maxim Biotech Inc,
Kvantify,
Shandong Bona Biological Technology Group Co., Ltd.,
Proteckthor,
Phycin,
Mingceler Turbomice.
Leuko's support email address is contact@leuko.io
Leuko's categories are Medical Equipment Manufacturing
Leuko's founding year is 2017
